HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.

HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.

Show other versions (1)

Hematopoietic stem cell transplantation (HSCT) still remains the only definitive cure currently available for patients with thalassemia and sickle cell anemia.  Results of transplant in thalassemia  and in sickle cell anemia  have steadily improved over the last two decades due to improvements in pr...

Full description

Bibliographic Details
Main Authors: Marco Marziali, Antonella Isgrò, Javid Gaziev, Guido Lucarelli
Format: Article
Language:English
Published: PAGEPress Publications 2009-12-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Hematopoietic Stem Cell Transplantation, Thalassemia , Sickle Cell Disease, Developping Countries
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/114

Internet

http://www.mjhid.org/index.php/mjhid/article/view/114

Similar Items